Westwood Management Has Trimmed Thermo Fisher Scientific (TMO) Stake By $1.40 Million; Orbcomm (ORBC)’s Sentiment Is 1.06

June 30, 2017 - By Louis Casey

ORBCOMM Inc. is a provider of Internet of Things solutions, including network connectivity, devices, device management and Web reporting applications. The company has market cap of $800.69 million. The Company’s IoT services and products are designed to track, monitor and manage security for a range of assets, such as trailers, trucks, rail cars, sea containers, generators, fluid tanks, marine vessels, diesel or electric powered generators (gensets), gas and oil wells, pipeline monitoring equipment, irrigation control systems, and utility meters, in industries for transportation and supply chain, heavy equipment, fixed asset monitoring, maritime and government. It currently has negative earnings. It also provides Automatic Identification System (AIS) data services to assist in vessel navigation and to manage maritime safety for government and commercial clients across the world.

Westwood Management Corp decreased Thermo Fisher Scientific Inc. (TMO) stake by 4.62% reported in 2016Q4 SEC filing. Westwood Management Corp sold 9,960 shares as Thermo Fisher Scientific Inc. (TMO)’s stock rose 8.13%. The Westwood Management Corp holds 205,411 shares with $28.98M value, down from 215,371 last quarter. Thermo Fisher Scientific Inc. now has $67.46B valuation. The stock rose 0.22% or $0.39 reaching $174.29. About 266,388 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since June 30, 2016 and is uptrending. It has underperformed by 1.13% the S&P500.

About 110,021 shares traded. ORBCOMM Inc (ORBC) has risen 5.18% since June 30, 2016 and is uptrending. It has underperformed by 11.52% the S&P500.

Since January 1, 0001, it had 0 insider purchases, and 12 sales for $1.20 million activity.

Levy Harkins & Co Inc holds 9% of its portfolio in ORBCOMM Inc for 2.85 million shares. Venator Capital Management Ltd. owns 399,403 shares or 2.99% of their US portfolio. Moreover, Goodman Financial Corp has 2.54% invested in the company for 549,116 shares. The Colorado-based Rk Capital Management Llc has invested 1.11% in the stock. Skylands Capital Llc, a Wisconsin-based fund reported 631,450 shares.

Investors sentiment increased to 1.05 in Q4 2016. Its up 0.26, from 0.79 in 2016Q3. It improved, as 52 investors sold TMO shares while 371 reduced holdings. 116 funds opened positions while 329 raised stakes. 330.70 million shares or 0.57% less from 332.58 million shares in 2016Q3 were reported. Baystate Wealth Management Ltd Limited Liability Company has 0% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Moreover, Banced has 0.72% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Hbk Sorce Advisory Ltd Com has 4,812 shares. Ruggie Capital Gp owns 29 shares for 0% of their portfolio. Picton Mahoney Asset owns 1.08% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 93,400 shares. Raymond James And Associates accumulated 130,950 shares or 0.05% of the stock. Amica Retiree Med holds 0.27% or 2,368 shares in its portfolio. E&G Advisors Limited Partnership invested 0.25% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Agf Investments holds 14,547 shares. Lincoln Natl stated it has 1,919 shares. 29,175 are owned by Tcw Grp Inc. Beacon Tru accumulated 2,147 shares or 0.05% of the stock. Moreover, Advantus Capital Management has 0.15% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Impax Asset Mgmt Ltd accumulated 213,532 shares or 1.33% of the stock. Cls Ltd accumulated 0% or 406 shares.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on July, 27. They expect $2.25 earnings per share, up 10.84% or $0.22 from last year’s $2.03 per share. TMO’s profit will be $870.88 million for 19.37 P/E if the $2.25 EPS becomes a reality. After $2.08 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 8.17% EPS growth.